Some doctors spend their careers following protocol. Christopher Duma spent his rewriting it. As a board-certified neurosurgeon based in Newport Beach, California, he has built a reputation not just for treating complex brain tumors but for pioneering new ways to fight them. His work spans traditional surgical suites, cutting-edge radiosurgery technology, and now, stem cell research aimed at neurodegenerative diseases like Alzheimer’s.
What sets Dr. Duma apart isn’t just his medical training, though that alone is impressive. It’s his consistent drive to innovate. He holds a patent for a novel glioblastoma treatment, serves as Medical Director of Hoag Hospital’s Brain Tumor Program, and founded his own biomedical company to push regenerative medicine forward. Add in a childhood dream sparked by his own family doctor, and you get a physician whose entire career reflects sustained, purposeful ambition. This article walks through how Christopher Duma built that career, one milestone at a time.
Who Is Dr. Christopher Duma?
Christopher Duma is a board-certified neurosurgeon practicing in Newport Beach, California, with more than three decades of experience treating some of the most complex conditions in medicine. He specializes in brain and spinal tumors, pituitary surgery, skull base surgery, and stereotactic and functional neurosurgery, a combination that places him among a select group of surgeons capable of handling both traditional open procedures and advanced radiosurgical techniques.
Read more: /jamie-koepp-biography/
Beyond his clinical work, Duma has built a name for himself as an innovator. He currently serves as Medical Director of the Hoag Brain Tumor Program and the Hoag/UCI Gamma Knife Program, while also holding an academic appointment as Assistant Clinical Professor at the University of California, Irvine. His career reflects a rare mix of hands-on surgical expertise, research-driven innovation, and academic mentorship, all centered around one consistent mission: improving outcomes for patients facing the most frightening diagnoses in neurology.
Christopher Duma Quick Bio and Career Facts
Before diving deeper into his story, here’s a table summarizing the key facts of Christopher Duma’s education, career, and achievements.
| Field | Detail |
|---|---|
| Full Name | Christopher Michael Duma |
| Born | New York City |
| Profession | Board-certified neurosurgeon, brain tumor specialist |
| Undergraduate Education | Colgate University — Neuroscience |
| Medical School | Stony Brook University Health Sciences Center School of Medicine (MD, 1986) |
| Residency | Georgetown University Hospital — Neurosurgery, 7 years, named Chief Resident |
| Fellowship | University of Pittsburgh — Stereotactic and Functional Neurosurgery, Gamma Knife Radiosurgery (1991) |
| Current Roles | Medical Director, Hoag Brain Tumor Program; Medical Director, Hoag/UCI Gamma Knife Program; Assistant Clinical Professor, UC Irvine |
| Company Founded | Regeneration Biomedical, Inc. (President and Founder) |
| Notable Achievement | Patent holder for a novel glioblastoma treatment |
| Recognition | Marquis Who’s Who in the World (2020) |
| Practice Location | Newport Beach, California |
| Years in Practice | Since 1993 (35+ years experience) |
| Languages | English, French |
This table shows a career built on layered achievement, moving from rigorous academic training into clinical leadership, and eventually into original medical research and patent-holding innovation.
Personal information
Full Name
His full name is Christopher Michael Duma.
Born
He was born in New York City.
Profession
He is a board-certified neurosurgeon and brain tumor specialist.
Undergraduate Education
He studied Neuroscience at Colgate University.
Medical School
He earned his MD from Stony Brook University Health Sciences Center School of Medicine in 1986.
Residency
He completed a seven-year neurosurgery residency at Georgetown University Hospital, where he was named Chief Resident.
Fellowship
He completed a fellowship at the University of Pittsburgh in Stereotactic and Functional Neurosurgery and Gamma Knife Radiosurgery in 1991.
Current Roles
He serves as Medical Director of the Hoag Brain Tumor Program, Medical Director of the Hoag/UCI Gamma Knife Program, and Assistant Clinical Professor at UC Irvine.
Company Founded
He founded Regeneration Biomedical, Inc., where he serves as President and Founder.
Notable Achievement
He holds a patent for a novel glioblastoma treatment.
Recognition
He was inducted into Marquis Who’s Who in the World in 2020.
Practice Location
He practices in Newport Beach, California.
Years in Practice
He has been in practice since 1993, with over 35 years of experience.
Languages
He speaks English and French.
Early Life and Inspiration to Become a Doctor
Christopher Duma was born in New York City, though most public records focus on his professional rather than early personal life. What is documented, and genuinely compelling, is the specific spark that set him on his medical path. According to his own account, Duma wanted to become a doctor since the age of nine, inspired directly by his family doctor, who served as an early role model for the kind of care and expertise he would later spend decades developing himself.
This kind of early, specific inspiration is not uncommon among physicians, but it’s rare to see it documented so clearly and consistently across a doctor’s public profile. It suggests that Duma’s eventual specialization in neurosurgery, one of medicine’s most demanding and high-stakes fields, wasn’t a career pivot or a fallback choice. It was a long-held ambition, pursued deliberately from childhood through decades of rigorous academic and surgical training. That early motivation likely helps explain the sustained intensity of his career, which has consistently pushed beyond standard clinical practice into genuine medical innovation.
Christopher Duma’s Education at Colgate University
Duma’s formal academic journey began at Colgate University, where he majored in Neuroscience as an undergraduate. Choosing neuroscience as an undergraduate major already signals early specialization, since many pre-medical students opt for broader biology or chemistry tracks before narrowing their focus in medical school. Duma’s decision to study neuroscience specifically suggests that his interest in the brain and nervous system was already well-formed by the time he entered college.
Colgate University, a liberal arts institution known for strong pre-professional preparation, gave Duma a solid academic foundation before he moved into the more specialized world of medical school. Undergraduate neuroscience training typically covers brain anatomy, neural pathways, and the biological basis of cognition and behavior, all of which would become directly relevant to his later surgical specialization. This early academic choice reflects the same focused ambition that defined his childhood inspiration to become a doctor, carried forward into a concrete, structured course of study.
Medical School at Stony Brook University
After completing his undergraduate degree, Duma pursued his medical degree at the Stony Brook University Health Sciences Center School of Medicine, now known as the Renaissance School of Medicine at Stony Brook University. He graduated in 1986, earning the MD credential that would allow him to begin formal surgical training.
Stony Brook’s medical program is part of the State University of New York system and has a strong reputation for producing well-rounded physicians across multiple specialties. Completing medical school is a demanding, multi-year process involving both classroom instruction and clinical rotations across different medical fields, giving future doctors broad exposure before they specialize. For Duma, this period represented the transition from academic study of the nervous system into the practical, hands-on medical training that would eventually lead him toward neurosurgery specifically. His 1986 graduation date places the start of his residency training shortly afterward, beginning the next demanding chapter of his medical career.
Neurosurgery Residency at Georgetown University Hospital
Following medical school, Duma completed his neurosurgery residency at Georgetown University Hospital, a rigorous seven-year training program that represents one of the most demanding paths in all of medicine. Neurosurgery residencies are notoriously long and intense, often requiring more years of training than almost any other surgical specialty due to the complexity and risk involved in operating on the brain and spinal cord.
What stands out in Duma’s residency record is that he was named Chief Resident during his final year, a leadership position reserved for the most capable and trusted residents in a training program. Being selected as chief resident isn’t just a title. It reflects recognition from supervising surgeons that a trainee has demonstrated both the technical skill and the judgment necessary to help guide and mentor other residents. Completing this residency at Georgetown, followed by chief resident status, gave Duma the clinical foundation and leadership experience that would later support his transition into hospital administration roles, including his eventual position as Medical Director at Hoag Hospital.
Fellowship Training at the University of Pittsburgh
After finishing his residency, Duma pursued additional specialized training through a fellowship at the University of Pittsburgh, completed in 1991. This fellowship focused specifically on Stereotactic and Functional Neurosurgery and Gamma Knife Radiosurgery, two highly specialized techniques that go beyond standard neurosurgical training.
Stereotactic neurosurgery involves using precise three-dimensional coordinate systems to target very specific areas of the brain, often for conditions like tumors, movement disorders, or epilepsy, while minimizing damage to surrounding healthy tissue. Gamma Knife radiosurgery, meanwhile, uses focused beams of radiation to treat brain lesions without traditional open surgery at all. Training in both techniques at a program as respected as the University of Pittsburgh’s positioned Duma at the leading edge of radiosurgery technology early in his career, well before these techniques became widely adopted across the field. This fellowship essentially completed his formal training, equipping him with both traditional surgical skill and access to some of the most advanced, minimally invasive treatment options available in neurosurgery.
Christopher Duma’s Career as Medical Director at Hoag Hospital
With his residency and fellowship complete, Duma built the bulk of his clinical career at Hoag Memorial Hospital Presbyterian in Newport Beach, California, where he has practiced since 1993. Over more than three decades, he rose to serve as Medical Director of both the Hoag Brain Tumor Program and the Hoag/UCI Gamma Knife Program, positions that place him in charge of coordinating complex, multidisciplinary care for patients facing some of the most serious neurological diagnoses.
Serving as Medical Director of a hospital program involves far more than individual patient care. It requires overseeing treatment protocols, coordinating between surgical and radiosurgical teams, and ensuring a hospital program maintains the highest possible standards of patient outcomes. Duma also holds a Volunteer Faculty appointment and serves as Assistant Clinical Professor in the Department of Medicine at the University of California, Irvine, extending his influence beyond direct patient care into academic mentorship for the next generation of physicians. His long tenure at Hoag Hospital reflects deep institutional trust, built through consistent clinical excellence over more than 30 years.
Pioneering Gamma Knife and CyberKnife Radiosurgery
Throughout his career, Duma has specialized in advanced radiosurgical techniques, particularly Gamma Knife and CyberKnife radiosurgery. Both technologies allow surgeons to treat brain tumors and other neurological conditions using precisely focused radiation beams, avoiding the risks associated with traditional open-skull surgery whenever clinically appropriate.
Duma’s expertise in 3-dimensional computer-assisted operative brain surgery further reflects his commitment to precision-based treatment approaches. These techniques require not just surgical skill but genuine technological fluency, since radiosurgery systems rely heavily on advanced imaging and computer-guided targeting to achieve accurate results. As Medical Director of the Hoag/UCI Gamma Knife Program specifically, Duma has helped establish Orange County as a regional center for this kind of advanced, minimally invasive neurosurgical care. Patients with conditions that once required extensive open surgery can now, in many cases, receive treatment through these radiosurgical alternatives, a shift in medical practice that Duma has actively helped drive throughout his career.
Christopher Duma’s Patent for Glioblastoma Treatment
Perhaps the most significant marker of Duma’s contribution to medicine is that he is the creator and patent holder of a widely adopted novel treatment for glioblastoma, one of the most aggressive and difficult-to-treat forms of brain cancer. Glioblastoma is notoriously resistant to standard treatment, with historically poor survival rates that have made it a major focus of ongoing cancer research worldwide.
Holding a patent for a treatment method that has seen wide adoption represents a genuinely rare achievement in clinical neurosurgery. Most practicing surgeons focus entirely on applying existing techniques rather than developing and patenting entirely new treatment approaches. Duma’s work in this area, delivered through a TEDx talk titled “Leading-Edge Pinpoint Radiation Technique on Glioblastoma,” reflects his broader identity as a pioneer in glioblastoma treatment rather than simply a practicing clinician. This innovation likely stems directly from his combined training in both traditional surgery and advanced radiosurgical techniques, giving him the technical foundation needed to develop genuinely new treatment protocols for one of neuro-oncology’s most challenging diagnoses.
Founding Regeneration Biomedical Inc. and Stem Cell Research
Beyond his clinical and radiosurgical work, Duma has expanded into an entirely new frontier of medicine by founding Regeneration Biomedical, Inc. (RBI), a clinical-stage company based in Newport Beach where he serves as President and Founder. The company specializes in developing and applying stem cell therapies for neurodegenerative diseases, marking a significant expansion beyond his original surgical specialty.
Most notably, Duma has been instrumental in advancing RBI’s research toward a Phase 1 clinical trial for a stem cell therapy targeting Alzheimer’s disease patients, one of the most urgently needed areas of modern medical research given the rapidly aging global population. He frequently presents the company’s findings at scientific conferences, positioning himself at the intersection of clinical neurosurgery and cutting-edge regenerative medicine. This shift from surgical treatment toward stem cell research reflects a natural evolution for a physician already established as an innovator, extending his impact from treating existing brain conditions toward potentially reversing or slowing neurodegenerative disease processes altogether.
Academic Role as Assistant Clinical Professor at UC Irvine
Alongside his clinical and research work, Duma holds an academic appointment as Assistant Clinical Professor in the Department of Medicine at the University of California, Irvine, along with a Volunteer Faculty position at the same institution. This academic role allows him to contribute directly to medical education, likely involving mentorship of residents, fellows, or medical students working within UC Irvine’s affiliated hospital network.
Academic appointments like this matter because they extend a physician’s influence beyond individual patient care into the training of future doctors. Given Duma’s specific expertise in radiosurgery, glioblastoma treatment, and stem cell research, his mentorship likely exposes trainees to genuinely cutting-edge approaches in neurosurgery and neuro-oncology, knowledge that might not be available through standard textbook education alone. Combining an academic teaching role with active clinical practice and ongoing research reflects Duma’s comprehensive approach to advancing his field, not just through direct patient treatment, but through knowledge transfer to the next generation of physicians as well.
Marquis Who’s Who Recognition and Professional Honors
In November 2020, Duma received significant recognition when he was inducted into Marquis Who’s Who in the World, a prestigious registry honoring accomplished professionals across various fields based on their achievements, leadership, and lasting impact. According to the announcement, Duma was specifically celebrated for his decades of innovation in surgical techniques for treating complex brain tumors.
This recognition adds to a broader list of professional honors Duma has received throughout his career, including acknowledgment from the American Association of Neurological Surgeons and the American College of Surgeons, two of the most respected professional bodies in his field. Being recognized by both peer organizations and a prestigious external registry like Marquis Who’s Who reflects sustained excellence rather than a single notable achievement. For a physician whose career spans clinical practice, radiosurgical innovation, patent-holding treatment development, and now stem cell research, this kind of comprehensive recognition affirms his standing as a genuinely influential figure within modern neurosurgery.
Christopher Duma’s Personal Life — Rock Band, Boating, and Travel
Despite an intensely demanding medical career, Duma maintains a documented personal life outside the operating room. According to his Marquis Who’s Who profile, he enjoys travel, boating, and playing in his own rock band, hobbies that offer a different rhythm from the precision and high stakes of neurosurgical practice.
These personal details, while modest compared to the depth of his professional achievements, humanize a career otherwise defined by clinical titles and medical innovation. Playing in a rock band, in particular, suggests a creative outlet that stands in sharp contrast to the highly technical, evidence-based world of brain surgery and radiosurgical treatment. Many physicians in demanding specialties like neurosurgery cite creative or physical hobbies as essential for managing the intense pressure of their work, and Duma’s documented interests suggest he has found his own balance between the analytical rigor of his profession and more expressive, recreational pursuits away from the hospital.
Christopher Duma’s Legacy in Modern Neurosurgery
Taken as a whole, Christopher Duma’s career reflects a rare combination of surgical excellence, technological innovation, and forward-looking research. From his childhood inspiration at age nine, through rigorous training at Colgate, Stony Brook, Georgetown, and the University of Pittsburgh, to his current work as Medical Director at Hoag Hospital and founder of Regeneration Biomedical, Duma has consistently pushed beyond conventional practice toward genuine medical advancement.
His patent for a novel glioblastoma treatment alone would represent a significant career achievement for most neurosurgeons. Combined with his pioneering work in Gamma Knife and CyberKnife radiosurgery, his current research into stem cell therapy for Alzheimer’s disease, and his recognition through Marquis Who’s Who in the World, Duma’s career stands as a genuine example of how clinical practice and original research can reinforce each other over a multi-decade career. As neurosurgery and regenerative medicine continue to evolve, Christopher Duma’s ongoing work positions him at the forefront of that progress, treating today’s patients while actively researching tomorrow’s treatments.
FAQs About Christopher Duma
Who is Dr. Christopher Duma?
He’s a board-certified neurosurgeon based in Newport Beach, California, specializing in brain and spinal tumors, pituitary surgery, and advanced radiosurgery techniques.
Where did Christopher Duma go to medical school?
He earned his MD from the Stony Brook University Health Sciences Center School of Medicine (now the Renaissance School of Medicine) in 1986.
Where did Christopher Duma complete his residency?
He completed a seven-year neurosurgery residency at Georgetown University Hospital, where he was named Chief Resident.
What is Christopher Duma known for in neurosurgery?
He is best known as the creator and patent holder of a novel, widely adopted treatment for glioblastoma, an aggressive form of brain cancer.
What hospital is Christopher Duma affiliated with?
He practices at Hoag Memorial Hospital Presbyterian in Newport Beach, California, where he serves as Medical Director of the Brain Tumor Program and the Gamma Knife Program.
What company did Christopher Duma found?
He founded Regeneration Biomedical, Inc., a clinical-stage company developing stem cell therapies for neurodegenerative diseases like Alzheimer’s.
Does Christopher Duma teach or hold an academic position?
Yes, he serves as Assistant Clinical Professor in the Department of Medicine at the University of California, Irvine.
What awards or recognitions has Christopher Duma received?
He was inducted into Marquis Who’s Who in the World in 2020 and has been honored by the American Association of Neurological Surgeons and the American College of Surgeons.
What inspired Christopher Duma to become a doctor?
He has said he wanted to become a doctor since age nine, inspired by his own family doctor growing up.
What are Christopher Duma’s hobbies outside medicine?
He enjoys travel, boating, and playing in his own rock band.
Conclusion
Christopher Duma’s career shows what happens when early ambition meets decades of disciplined training and genuine innovation. From a childhood dream sparked by a family doctor to becoming a patent-holding pioneer in glioblastoma treatment, his path through Colgate University, Stony Brook, Georgetown, and the University of Pittsburgh built the foundation for a career defined by both surgical excellence and research-driven progress.
Today, as Medical Director at Hoag Hospital, founder of Regeneration Biomedical, and a recognized honoree in Marquis Who’s Who in the World, Christopher Duma continues pushing neurosurgery forward, one patient and one research breakthrough at a time. His work bridges traditional surgical care with cutting-edge stem cell research, positioning him as a genuinely influential figure in the ongoing fight against some of medicine’s most challenging neurological conditions.
